Client News
Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis
CANTON, Mass., January 14, 2021 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that […]
Exergen Corporation Delivers on its Mission to Meet Thermometer Demand – Because Accuracy Matters
New Campaigns Incentivize People to Trade-In Their Non-Contact Thermometers; Motivate Employers to Protect Nurses, and Educate Consumers About Twice Daily Temperature Taking at Home
Since COVID-19 hit nearly a year ago, Exergen Corporation’s mission has been to meet the unprecedented demand […]
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
Dynasil Appoints Militram Futuristic Technologies to Target Israel’s Fast Growing Industrial, Commercial and Military Segments
VERO Biotech Named Top Two Stories of 2020 by Pulmonary Hypertension News
The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled nitric oxide (iNO), delivered through the Genosyl system, according to VERO Biotech, manufacturer of Genosyl.
MCRC Newsletters
Client News
Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis
CANTON, Mass., January 14, 2021 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today [...]
Exergen Corporation Delivers on its Mission to Meet Thermometer Demand – Because Accuracy Matters
New Campaigns Incentivize People to Trade-In Their Non-Contact Thermometers; Motivate Employers to Protect Nurses, and Educate Consumers About Twice Daily Temperature Taking at Home Since COVID-19 hit nearly a year ago, Exergen Corporation’s mission has been to meet [...]
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
CANTON, Mass., January 11, 2021 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today [...]
Dynasil Appoints Militram Futuristic Technologies to Target Israel’s Fast Growing Industrial, Commercial and Military Segments
Dynasil Corporation of America ("Dynasil" or the "Company"), a leading developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for homeland security, medical and industrial markets, today announces that it has appointed [...]
VERO Biotech Named Top Two Stories of 2020 by Pulmonary Hypertension News
The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled nitric oxide (iNO), delivered through the Genosyl system, according to VERO Biotech, manufacturer of Genosyl. Read more: https://pulmonaryhypertensionnews.com/2020/03/25/covid-19-patient-with-ph-treated-with-ino-via-genosyl-vero-biotech-announces/